Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
82,773,190
-
Total 13F shares
-
55,065,784
-
Share change
-
+791,385
-
Total reported value
-
$1,544,975,458
-
Put/Call ratio
-
57%
-
Price per share
-
$28.06
-
Number of holders
-
230
-
Value change
-
+$17,229,403
-
Number of buys
-
118
-
Number of sells
-
92
Institutional Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q3 2020
As of 30 Sep 2020,
Editas Medicine, Inc. - Common Stock (EDIT) was held by
230 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
55,065,784 shares.
The largest 10 holders included
ARK Investment Management LLC, VANGUARD GROUP INC, BlackRock Inc., Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., STATE STREET CORP, Capital World Investors, FEDERATED HERMES, INC., Chevy Chase Trust Holdings, Inc., and MORGAN STANLEY.
This page lists
232
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.